FDA Issues Recalls for Chlorthalidone and Exenatide Prefilled Pens

The FDA has announced recalls for chlorthalidone 25 mg tablets due to dissolution issues, marking its second recall in three months. Additionally, exenatide injection prefilled pens are being recalled because of a defective delivery system that may result in no medication being dispensed. These recalls are important for patient safety, ensuring medication efficacy and proper dosing.